Does Microdosing Mushrooms Work? The Placebo Puzzle
A lemon you never bite, a milkshake with the wrong label, and capsules sealed in envelopes. Why expectation is a physical force, and why it makes microdosing so hard to study.
Quick answer
Under blinded conditions, much of the reported benefit of microdosing tracks expectation. In a 2021 self-blinding study of 191 microdosers, the placebo group improved too, and the groups did not differ significantly over four weeks. A 2022 double-blind trial of dried mushrooms found no benefit on well-being, creativity or cognition. What remains once expectation is removed is still unknown.
You pick up a bright yellow lemon. You cut it in half, and the juice beads on the blade. You bite into it.
Chances are, your mouth just watered.
You haven’t swallowed a thing. Just by reading, your body has already reacted.
That’s no quirk. Physiologists call it the cephalic phase of digestion: the sight, the smell, even the thought of a meal can set off saliva and gastric juices, and the first taste starts insulin release before anything is swallowed. In a 1986 study, simply talking with volunteers about appetizing food was enough to make their stomachs start secreting acid.
The placebo has a bad reputation. We picture it as a sleight of hand, a way of being fooled by an illusion. That’s not what science says. Expectation is physiology, and it comes printed on every label, including the ones on psilocybin mushrooms for sale.

In brief
- Expectation is physical: the thought of food starts digestion, and in a 2011 study a label alone changed the hunger-hormone response to the same milkshake.
- Self-blinded microdosers: in a 2021 study, 191 people took real or empty capsules from QR-coded envelopes for four weeks.
- Placebo kept pace: the microdose group improved, the placebo group improved too, and on the four-week measures the groups did not differ significantly.
- Belief tracked results: participants guessed right about 72% of the time (chance in this design was roughly 63%), and believing they had microdosed went with better scores in 21 of 22 comparisons.
- Mushrooms, double-blind: a 2022 trial of 0.5 g dried mushrooms found stronger effects only among those who guessed right, and no benefit on creativity, well-being or cognition.
1. Mind Over Milkshake: How a Label Changed a Hormone
In 2011, psychologist Alia Crum, then at Yale, took the idea further. She served 46 volunteers the same milkshake on two occasions a week apart: same recipe, 380 calories. Only the label changed. Once it was an “indulgent” 620-calorie shake. Once, a “sensible” 140-calorie shake.
After they drank it, their bodies told two different stories. When they thought they’d treated themselves, ghrelin, the hunger hormone, dropped sharply, as it would after a rich meal. When they thought they’d been sensible, it barely moved.
How can a label change a hormone? An influential theory in neuroscience offers an explanation. The brain doesn’t just react to what happens to it: it’s a prediction machine. To save energy, it constantly anticipates what the body is about to need, and prepares it accordingly. If the label announces a feast, the body gets ready for a feast.
So expectation can change what the body does.
And that raises a much bigger question: does microdosing mushrooms really work? If a label can change your hormones, what can a capsule marked “microdose” do? Anyone deciding to buy shrooms online faces the same question, because every pack of microdose mushroom gummies carries a label, and every label carries an expectation.
To find out what a substance really does, you first have to take expectation out of the equation.

Crum AJ, Corbin WR, Brownell KD, Salovey P. Mind over milkshakes: Mindsets, not just nutrients, determine ghrelin response. 46 participants drank the same 380-calorie shake labeled “indulgent” or “sensible” on two occasions; the indulgent label produced a steeper decline in ghrelin.
Read the 2011 study ↗2. With Psychedelics, the Blindfold Slips
The blindfold is science’s golden rule for neutralizing the placebo effect. One group gets the substance, the other an identical placebo, and nobody knows who got what. With psychedelics, though, the blindfold tends to slip: even at low doses, people often guess what they’ve taken.
In 2021, a team at Imperial College London found a clever way around the problem.
Instead of bringing microdosers into a lab, the researchers asked them to run the experiment themselves, at home, at their kitchen tables.
Each participant prepared two kinds of opaque capsules: some with their usual microdose, others empty. They sealed them into identical, unlabeled envelopes marked only with a QR code, then shuffled them. For four weeks, they took their capsules without knowing what was inside. Only the researchers could read the truth.
Those envelopes were the opposite of a product page: no brand, no strain name, nothing like the promise printed on a pack of magic mushroom gummies.
240 people started, and 191 saw it through. One important detail: about three in four were microdosing LSD or a close analogue, and a quarter were microdosing psilocybin mushrooms.
3. What 191 Self-Blinded Volunteers Found About Microdosing Psilocybin
The result surprised many. The microdose group improved on every psychological measure, from well-being to life satisfaction. But the placebo group, who had swallowed only empty capsules, improved too, and on those four-week measures the groups did not differ significantly. Small differences on the day of dosing, in mood and energy, were explained by people guessing what they had taken.
Then the researchers asked another question: what do you think you took?
Participants guessed right about 7 times out of 10. And those who believed they’d taken a microdose felt better, whether they had actually taken one or not. In 21 of 22 comparisons, people who believed they had taken a microdose did better than people who had taken the same thing but guessed placebo. The authors’ conclusion: the reported benefits of microdosing “can be explained by the placebo effect.”
Szigeti B, Kartner L, Blemings A, et al. Self-blinding citizen science to explore psychedelic microdosing. 191 completers, four-week dose period, opaque capsules in QR-coded envelopes. Both groups improved; no significant between-group differences; correct guesses about 72% of the time.
Read the 2021 study ↗4. Shrooms Microdosing in a Double-Blind Trial: The Argentina Study
A year later, a team in Argentina ran a more classic double-blind trial, this time with mushrooms. In this shrooms microdosing study, 34 participants took two doses of 0.5 g of dried Psilocybe cubensis one week and a placebo another week. Those on the real dose did report stronger effects, but only if they had guessed what they were taking. On creativity, well-being or cognition, there was no measurable benefit, and a few small changes pointed toward slightly worse cognitive performance. For the researchers, expectation explains “at least some” of the benefits attributed to microdosing.
Neither trial used a store-bought product. The capsules in London were filled by the participants themselves; the mushrooms in Buenos Aires were prepared for the study. Nothing here was a commercial product: no magic mushroom capsules, no shroom gummies, no brand.
| Claim you will see | What the studies showed | What they did not show |
|---|---|---|
| “Microdosing works” | People who microdosed felt better over four weeks (2021) | That they felt better than people taking empty capsules |
| “It’s all placebo” | Belief tracked outcomes in 21 of 22 comparisons (2021) | That a real dose does nothing; real doses felt stronger |
| “You can feel it” | Stronger acute effects, only among those who guessed right (2022) | A benefit on creativity, well-being or cognition |
| “A label tells you the dose” | Nothing; no product was tested | How much psilocybin any capsule contains |
Cavanna F, Muller S, de la Fuente LA, et al. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. 34 participants, 0.5 g dried mushrooms twice in one week vs placebo. Stronger acute effects only among those who identified their condition; no benefit on well-being, creativity or cognition.
Read the 2022 study ↗The World’s Biggest Placebo-Controlled Microdosing Study — Dr Balázs Szigeti
A 2021 Drug Science webinar in which the lead author of the self-blinding study explains its design and results. Third-party presentation; it does not discuss the Argentina trial.
5. Before You Buy Shroom Gummies Online: What These Studies Don’t Say
None of this means microdosing “doesn’t work.” It’s more nuanced than that.
The studies are still small, and their participants were often volunteers who were already convinced, people who were microdosing before they ever signed up. The blindfold slips: once people guess what they’ve taken, separating the two forces becomes almost impossible. There’s a limit, though: expectation can’t conjure the molecule. In both studies, people who took a real dose felt its effects more intensely; what belief seemed to shape was something the brain can already produce on its own, like mood and a sense of well-being.
Type “where can I buy magic mushrooms” and the results are a wall of labels on magic mushrooms for sale. The milkshake study is a reminder of what a label can do on its own, which makes it the thing to read most carefully.
Mushrooms add their own uncertainty: their psilocybin content varies from batch to batch. That’s why a label showing a weight of mushroom doesn’t tell you, on its own, how much psilocybin a capsule contains, and why iMicrodosing publishes lab reports for its batches.
So before buying magic mushrooms online, read past the promise on the front to the paperwork behind it, the part of a label expectation can’t write: a batch-specific certificate of analysis, a label that says what its milligrams measure, and whether that amount is per piece or per package. The same goes for psilocybin gummies and other shroom edibles, where one piece can hold a different share of the package total; our chocolate-bar editorial walks through that label.
When you weigh microdose mushroom companies or shrooms for sale against each other, a lab report is the one part of the label that doesn’t depend on what you expect. Psilocybin remains Schedule I under U.S. federal law, so check the rules where you live.

Here’s what science can say today: under the most controlled conditions, much of what people feel seems to come from what they expect. What remains once expectation is set aside, no one yet knows for sure. The same gap shows up in research on creativity, as our Creativity Capsules press release explains: an effect widely expected, rarely measured.
6. The Ingredient You Bring
Let’s go back to the milkshake.
Those volunteers weren’t fooled by their imagination. Their bodies genuinely responded, hormone by hormone, to what they believed they were drinking.
That may be the most surprising lesson of all. When we ask whether microdosing mushrooms works, we’re really asking two questions: what does the substance do, and what do we do with what we believe? Science is getting better and better at answering the second. It’s still searching for the answer to the first.
In the meantime, be as wary of headlines that shout “it works!” as of those that snap “it’s nonsense.” Both oversimplify. So do psilocybin products that promise a feeling on the front of the box.
Quick answers
- Does microdosing mushrooms work?
- Under the most controlled conditions, much of what people report seems to come from expectation. In a 2021 self-blinding study, the microdose and placebo groups both improved, with no significant difference between them on the four-week measures, and a 2022 double-blind trial of dried mushrooms found no benefit on well-being, creativity or cognition. What a microdose does beyond expectation is not yet known.
- Is microdosing just a placebo?
- The evidence so far says expectation explains much, not necessarily all, of it. In both the 2021 and 2022 studies, people who took a real dose felt its acute effects more intensely (in the 2022 trial, only among those who guessed correctly); what belief seemed to shape was mood and well-being.
- What was the self-blinding microdosing study?
- A 2021 Imperial College London study published in eLife. Participants filled opaque capsules with their usual microdose or nothing, sealed them in identical QR-coded envelopes and took them for four weeks without knowing which was which; 191 completed it.
- Can expectation change the body?
- Yes. The sight and smell of food set off saliva and gastric juices before eating, and in a 2011 Yale study the same 380-calorie milkshake produced a much steeper drop in the hunger hormone ghrelin when it was labeled “indulgent” than when it was labeled “sensible.”
- Where can I buy psychedelic mushroom gummies or capsules, and what should I check first?
- Neither study tested anything sold, so they can’t point you to a product. What they show is how much a label shapes expectation, which makes the label’s paperwork the part to trust: a batch-specific certificate of analysis, what the milligrams measure, and whether the amount is per piece or per package. Psilocybin remains Schedule I under U.S. federal law, so check the law where you live.
- Why is microdosing so hard to study?
- Because the blindfold slips. Even at low doses, people often guess whether they took the real thing, and once they guess, the effect of the substance and the effect of expectation are hard to separate. Mushroom potency also varies from batch to batch, so two people who buy psilocybin mushrooms of the same strain may not take the same amount of psilocybin. More in why microdosing research is difficult to study.
Research & references
- Power ML, Schulkin J (2008). Anticipatory physiological regulation in feeding biology: Cephalic phase responses. Appetite, 50(2–3), 194–206. doi:10.1016/j.appet.2007.10.006.
- Feldman M, Richardson CT (1986). Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology, 1986. PubMed 3940915.
- Crum AJ, Corbin WR, Brownell KD, Salovey P (2011). Mind over milkshakes: Mindsets, not just nutrients, determine ghrelin response. Health Psychology, 30(4), 424–429. doi:10.1037/a0023467.
- Barrett LF, Simmons WK (2015). Interoceptive predictions in the brain. Nature Reviews Neuroscience, 16, 419–429. doi:10.1038/nrn3950.
- Szigeti B, Kartner L, Blemings A, et al. (2021). Self-blinding citizen science to explore psychedelic microdosing. eLife, 10, e62878. doi:10.7554/eLife.62878.
- Cavanna F, Muller S, de la Fuente LA, et al. (2022). Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Translational Psychiatry, 12. doi:10.1038/s41398-022-02039-0.
- iMicrodosing.org. Placebo effects in microdosing research. imicrodosing.org; What counts as evidence in microdosing research. imicrodosing.org.
- iMicrodosing.org. What scientists mean by “microdosing” in research. imicrodosing.org; What a microdose is, and what it isn’t. imicrodosing.org.
- iMicrodosing, The Curious Side. New to microdosing mushrooms? Start with a few honest questions. imicrodosing.com.
- Drug Science (2021). The World’s Biggest Placebo-Controlled Microdosing Study, with Dr Balázs Szigeti. YouTube video (third-party presentation).
Editorial note: This publication is an original editorial for general education. It is not medical advice and does not diagnose, treat, cure or prevent any condition. Neither study described here tested a consumer product. Psilocybin remains a Schedule I controlled substance under U.S. federal law (as of October 2026); know and follow the laws where you live. For adults 21 and over. The three images are AI-generated editorial illustrations, not photographs or figures from the cited studies. Sources are linked directly so readers can distinguish documented findings from general observations.
← All editorials